Targeted therapies for the treatment of non-small-cell lung cancer: Monoclonal antibodies and biological inhibitors.
about
Dual-Color Bioluminescent Sensor Proteins for Therapeutic Drug Monitoring of Antitumor Antibodies.Real world study of regimen containing bevacizumab as first-line therapy in Chinese patients with advanced non-small cell lung cancer.Simultaneous evaluation of anti-EGFR-induced tumour and adverse skin effects in a microfluidic human 3D co-culture modelThe efficacy and safety of ALK inhibitors in the treatment of ALK-positive non-small cell lung cancer: A network meta-analysis
P2860
Targeted therapies for the treatment of non-small-cell lung cancer: Monoclonal antibodies and biological inhibitors.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Targeted therapies for the tre ...... ies and biological inhibitors.
@en
Targeted therapies for the tre ...... ies and biological inhibitors.
@nl
type
label
Targeted therapies for the tre ...... ies and biological inhibitors.
@en
Targeted therapies for the tre ...... ies and biological inhibitors.
@nl
prefLabel
Targeted therapies for the tre ...... ies and biological inhibitors.
@en
Targeted therapies for the tre ...... ies and biological inhibitors.
@nl
P2093
P2860
P921
P1476
Targeted therapies for the tre ...... ies and biological inhibitors.
@en
P2093
Ana P S Silva
Maristella Anazetti
Priscila V Coelho
P2860
P304
P356
10.1080/21645515.2016.1249551
P5008
P577
2016-11-10T00:00:00Z
2017-04-03T00:00:00Z